Literature DB >> 22500537

Polypharmacy, adverse drug reactions, and geriatric syndromes.

Bhavik M Shah1, Emily R Hajjar.   

Abstract

The elderly are at risk for polypharmacy, which is associated with significant consequences such as adverse effects, medication nonadherence, drug-drug and drug-disease interactions, and increased risk of geriatric syndromes. Providers should evaluate all existing medications at each patient visit for appropriateness and weigh the risks and benefits of starting new medications to minimize polypharmacy.

Entities:  

Mesh:

Year:  2012        PMID: 22500537     DOI: 10.1016/j.cger.2012.01.002

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  75 in total

1.  A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harm.

Authors:  Cameron J McDonald; Lisa M Kalisch Ellett; John D Barratt; Gillian E Caughey
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

2.  Clinical vignettes to help you deprescribe medications in elderly patients: Introduction to the polypharmacy case series.

Authors:  Barbara Farrell; Salima Shamji; Anne Monahan; Véronique French Merkley
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

3.  Development of a computer system to support medication reviews in nursing homes.

Authors:  Hugo A J M de Wit; Carlota Mestres Gonzalvo; Kim P G M Hurkens; Wubbo J Mulder; Rob Janknegt; Frans R Verhey; Jos M G A Schols; Paul-Hugo M van der Kuy
Journal:  Int J Clin Pharm       Date:  2013-10

4.  Reducing polypharmacy in the elderly: Cases to help you "rock the boat".

Authors:  Barbara Farrell; Salima Shamji; Anne Monahan; Véronique French Merkley
Journal:  Can Pharm J (Ott)       Date:  2013-09

5.  Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.

Authors:  Martin Wagner; Götz Gelbrich; Julia Kircher; Kornelia Kotseva; David Wood; Caroline Morbach; Rainer Leyh; Georg Ertl; Wolfgang Karmann; Stefan Störk; Peter U Heuschmann
Journal:  Int J Behav Med       Date:  2018-06

6.  Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estévez
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

Review 7.  Geriatric conditions and the risk of adverse drug reactions in older adults: a review.

Authors:  Fabrizia Lattanzio; Francesco Landi; Silvia Bustacchini; Angela Marie Abbatecola; Francesco Corica; Luigi Pranno; Andrea Corsonello
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

Review 8.  Polypharmacy and potentially inappropriate medication use in geriatric oncology.

Authors:  Manvi Sharma; Kah Poh Loh; Ginah Nightingale; Supriya G Mohile; Holly M Holmes
Journal:  J Geriatr Oncol       Date:  2016-08-03       Impact factor: 3.599

9.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

Review 10.  Adverse drug events as a cause of hospitalization in older adults.

Authors:  Fabio Salvi; Annalisa Marchetti; Federica D'Angelo; Massimo Boemi; Fabrizia Lattanzio; Antonio Cherubini
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.